Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synartro

Synartro
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of anti-inflammatory drug using the drug delivery technology. The company is involved in developing a pipeline of repositioned drug candidates for important medical needs.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Uppsala
  • Sweden

Synartro Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Synartro‘s full profile, request access.

Request full access to PitchBook

Synartro Executive Team (1)

Name Title Board
Seat
Contact
Info
Rune Ringom Chief Executive Officer